Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Scarsbrook

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2018
Discovery of pre-therapy 2-deoxy-2-<sup>18</sup>F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patientsMubarik A Arshad, Andrew Thornton, Haonan Lu, et al.
Annals of the Rheumatic Diseases|September 26, 2025
Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritisPaula David, Tom Macleod, Ala Altaie, et al.
BMJ Open|November 9, 2022
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)Jim Zhong, Sarah Brown, Maria Serra, et al.
Cancers|July 27, 2022
Exploratory Analysis of Serial <sup>18</sup>F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for GlioblastomaKavi Fatania, Russell Frood, Marcus Tyyger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2023
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancersStephane Niyoteka, Romain-David Seban, Rahimeh Rouhi, et al.
Nature Communications|March 15, 2026
An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancerStelios Theophanous, Per-Ivar Lønne, Ananya Choudhury, et al.
BMJ Open|January 4, 2024
Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK studyEmma O'Dowd, Marko Berovic, Matthew Callister, et al.
Diagnostic and Prognostic Research|August 3, 2022
Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 studyStelios Theophanous, Per-Ivar Lønne, Ananya Choudhury, et al.
BMJ Open|January 24, 2023
Protocol for a MULTI-centre feasibility study to assess the use of <sup>99m</sup>Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)Hannah Warren, Thomas Wagner, Michael A Gorin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2025
[<sup>99m</sup>Tc]Tc-sestamibi SPECT/CT for the diagnosis of kidney tumours: a multi-centre feasibility study (MULTI-MIBI Study)Hannah Warren, Thomas Wagner, Soha El-Sheikh, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2018
Discovery of pre-therapy 2-deoxy-2-<sup>18</sup>F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patientsMubarik A Arshad, Andrew Thornton, Haonan Lu, et al.
Annals of the Rheumatic Diseases|September 26, 2025
Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritisPaula David, Tom Macleod, Ala Altaie, et al.
BMJ Open|November 9, 2022
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)Jim Zhong, Sarah Brown, Maria Serra, et al.
Cancers|July 27, 2022
Exploratory Analysis of Serial <sup>18</sup>F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for GlioblastomaKavi Fatania, Russell Frood, Marcus Tyyger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2023
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancersStephane Niyoteka, Romain-David Seban, Rahimeh Rouhi, et al.
Nature Communications|March 15, 2026
An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancerStelios Theophanous, Per-Ivar Lønne, Ananya Choudhury, et al.
BMJ Open|January 4, 2024
Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK studyEmma O'Dowd, Marko Berovic, Matthew Callister, et al.
Diagnostic and Prognostic Research|August 3, 2022
Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 studyStelios Theophanous, Per-Ivar Lønne, Ananya Choudhury, et al.
BMJ Open|January 24, 2023
Protocol for a MULTI-centre feasibility study to assess the use of <sup>99m</sup>Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)Hannah Warren, Thomas Wagner, Michael A Gorin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2025
[<sup>99m</sup>Tc]Tc-sestamibi SPECT/CT for the diagnosis of kidney tumours: a multi-centre feasibility study (MULTI-MIBI Study)Hannah Warren, Thomas Wagner, Soha El-Sheikh, et al.
Pageof 7